Gene · 7994
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Landscape of mSWI/SNF chromatin remodeling complex perturbations in neurodevelopmental disorders. | Nat Genet | 2023 | 37500730 | PubTator, text mining | PubMed |
| CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. | Mol Cancer Res | 2023 | 37493631 | PubTator, text mining | PubMed |
| MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape. | J Biol Chem | 2023 | 37468105 | PubTator, text mining | PubMed |
| Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS. | NPJ Genom Med | 2023 | 37463940 | PubTator, text mining | PubMed |
| Epigenetic mechanisms to propagate histone acetylation by p300/CBP. | Nat Commun | 2023 | 37460559 | PubTator, text mining | PubMed |
| Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma. | Nat Commun | 2023 | 37460547 | PubTator, text mining | PubMed |
| Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. | Cancers (Basel) | 2023 | 37444622 | PubTator, text mining | PubMed |
| Down syndrome and leukemia: from basic mechanisms to clinical advances. | Haematologica | 2023 | 37439336 | PubTator, text mining | PubMed |
| The SMAD2/miR-4256/HDAC5/p16INK4a signaling axis contributes to gastric cancer progression. | Oncol Res | 2023 | 37415735 | PubTator, text mining | PubMed |
| Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis. | Res Sq | 2023 | 37398194 | PubTator, text mining | PubMed |
| Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing. | Technol Cancer Res Treat | 2023 | 37394872 | PubTator, text mining | PubMed |
| Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. | Exp Mol Med | 2023 | 37394580 | PubTator, text mining | PubMed |
| Ribosome biosynthesis and Hedgehog activity are cooperative actionable signaling mechanisms in breast cancer following radiotherapy. | NPJ Precis Oncol | 2023 | 37380890 | PubTator, text mining | PubMed |
| Cancer aneuploidies are shaped primarily by effects on tumour fitness. | Nature | 2023 | 37380777 | PubTator, text mining | PubMed |
| A Gene-Based Algorithm for Identifying Factors That May Affect a Speaker's Voice. | Entropy (Basel) | 2023 | 37372241 | PubTator, text mining | PubMed |
| RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis. | Cancers (Basel) | 2023 | 37370857 | PubTator, text mining | PubMed |
| Expression profiles and functional prediction of histone acetyltransferases of the MYST family in kidney renal clear cell carcinoma. | BMC Cancer | 2023 | 37365518 | PubTator, text mining | PubMed |
| Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects. | Stem Cell Res Ther | 2023 | 37357311 | PubTator, text mining | PubMed |
| Epigenetics: Novel crucial approach for osteogenesis of mesenchymal stem cells. | J Tissue Eng | 2023 | 37342486 | PubTator, text mining | PubMed |
| Integrated analysis of circRNA-associated ceRNA network in ischemic stroke. | Front Genet | 2023 | 37323662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7994/papers?page=11